Skip to main content

Table 2 Incidence and odds ratios for the development of MS according to baseline insulin quartile in 5 years of follow-up in whole cohort

From: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study

 

I(≤6.01)

(n = 592)

II (6.02-7.29)

(n = 585)

III(7.30-8.97)

(n = 588)

IV(≥8.98)

(n = 585)

Incident MS %(n)

3.9 (23/592)

5.1% (30/585)

8.5% (50/588)

16.4% (96/585)

Odds ratio (95% CI)

Model 1

1

1.4 (0.8 - 2.4)

2.5 (1.5 - 4.1) *

5.1 (3.1 - 8.2)*

Model 2

1

1.3 (0.7 - 2.4)

2.0 (1.2 - 3.4) †

3.6 (2.2 - 5.8)*

Model 3

1

1.2 (0.7 - 2.1)

1.7 (1.0 - 2.9)

3.0 (1.8 - 5.0)*

Model 4

1

1.1(0.6 - 2.1)

1.5 (0.9 - 2.5)

2.0 (1.2 - 3.3)†

  1. Adjusted factors in the models:
  2. Model 1: Gender, age, smoking status, exercise level, alcohol drinking amount, systolic blood pressure
  3. Model 2: Model 1 + HDL-cholesterol, triglyceride
  4. Model 3: Model 1 + HDL-cholesterol, triglyceride, fasting glucose
  5. Model 4: Model 1 + HDL-cholesterol, triglyceride, fasting glucose, waist circumference
  6. * p < 0.001
  7. † p < 0.05
  8. MS, metabolic syndrome; HDL, high-density lipoprotein; CI, confidence interval